AGBL4
Cytosolic carboxypeptidase 6
Also known as: CBPC6_HUMAN, CCP6, FLJ14442
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VU57
- Gene
- AGBL4
- Ensembl
- ENSG00000186094
- Chromosome
- 1
- Canonical length
- 503 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable metallocarboxypeptidase activity and tubulin binding activity. Predicted to be involved in C-terminal protein deglutamylation; defense response to virus; and protein side chain deglutamylation. Predicted to act upstream of or within several processes, including axonal transport of mitochondrion; positive regulation of ubiquitin-dependent protein catabolic process; and regulation of blastocyst development. Located in Golgi apparatus; centriole; and ciliary basal body. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
503 residues, UniProt reviewed canonical sequence.
>Q5VU57|AGBL4
1 MAEGSQSAPE AGNDMGNDDA IGGNVSKYIV LPTGYCGQPK KGHLIFDACF ESGNLGRVDQ
61 VSEFEYDLFI RPDTCNPRFR VWFNFTVENV KESQRVIFNI VNFSKTKSLY RDGMAPMVKS
121 TSRPKWQRLP PKNVYYYRCP DHRKNYVMSF AFCFDREEDI YQFAYCYPYT YTRFQHYLDS
181 LQKRNMDYFF REQLGQSVQQ RKLDLLTITS PDNLREGAEQ KVVFITGRVH PGETPSSFVC
241 QGIIDFLVSQ HPIACVLREY LVFKIAPMLN PDGVYLGNYR CSLMGFDLNR HWLDPSPWVH
301 PTLHGVKQLI VQMYNDPKTS LEFYIDIHAH STMMNGFMYG NIFEDEERFQ RQAIFPKLLC
361 QNAEDFSYSS TSFNRDAVKA GTGRRFLGGL LDHTSYCYTL EVSFYSYIIS GTTAAVPYTE
421 EAYMKLGRNV ARTFLDYYRL NPVVEKVAIP MPRLRNKEIE VQRRKEKSPP YKHPLLRGPA
481 SNYPNSKGDK KSSVNHKDPS TPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AGBL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 4.5 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 4.5 nTPM
- retina: 4.4 nTPM
- choroid plexus: 3.5 nTPM
- hypothalamus: 2.3 nTPM
- pituitary gland: 2.2 nTPM
- basal ganglia: 2.1 nTPM
Single-cell type
- thyrotrophs: 3,501 nCPM
- ependymal cells: 2,913 nCPM
- respiratory ciliated cells: 2,874 nCPM
- somatotrophs: 2,794 nCPM
- choroid plexus epithelial cells: 2,557 nCPM
- cone photoreceptor cells: 2,521 nCPM
Immune cell
- basophil: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 31 nTPM
- choroid plexus: 24 nTPM
- basal ganglia: 23 nTPM
- white matter: 21 nTPM
- hippocampal formation: 20 nTPM
- midbrain: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterograde axonal transport of mitochondrion
- C-terminal protein deglutamylation
- central nervous system neuron development
- defense response to virus
- negative regulation of cell population proliferation
- positive regulation of ubiquitin-dependent protein catabolic process
- protein deglutamylation
- protein side chain deglutamylation
- proteolysis
- regulation of blastocyst development
- retrograde axonal transport of mitochondrion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AGBL4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AGBL4 as an antibody target. Whether an autoantibody or antibody against AGBL4 could matter depends on whether native AGBL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AGBL4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AGBL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...